# Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer

> **NCT00888511** · PHASE2 · COMPLETED · sponsor: **Olfred Hansen** · enrollment: 15 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Tarceva
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT00888511
- **Lead sponsor:** Olfred Hansen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-11-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00888511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00888511, "Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00888511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*